Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BCAL Diagnostics Ltd

BDX.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Micro Cap Analyst: N/A

Last Close

$0.04

▲ +0.00%

Market Cap $14.56M · Vol 227.35K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$14.56M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

29.73

Momentum

Beta

0.53

vs Market

52W High

$0.11

61.87% below

52W Low

$0.04

18.54% above

Volume

227.35K

Avg 97.18K

P/B

3.71

Price-to-book

ROE

N/A

Return on equity

Free Float

47.29%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BCAL Diagnostics Ltd (BDX.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BDX.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-13.85%

-26.32%

-32.53%

-53.33%

YTD

-46.67%

-6.67%

-56.11%

-67.06%

Financials & Valuation

TTM · Annual

Total Revenue	$1.87M
Net Income	$-4,764,594.00
Revenue Growth (YoY)	-8.13%
Gross Margin	100.00%
Operating Margin	-249.20%
Net Profit Margin	-255.42%
ROE	N/A
ROA · ROIC	-65.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	7.99
P/B	3.71
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	368.68M

Technical Indicators

50-Day SMA	$0.05
200-Day SMA	$0.07
RSI (14)	29.73
Beta	0.53
52-Week High	$0.11
52-Week Low	$0.04

Volume Today	227.35K
Avg Daily Volume (30D)	97.18K
Relative Volume	2.34x
Volatility (10D)	96.00
Volatility (30D)	81.36
Free Float	47.29%

Analyst Consensus

N/A

Current Price $0.04

Mean Target N/A

52W Low$0.04 52W High$0.11

Current

Target

$0.04 $0.11

Current Analyst target

· 1 analysts

Identifiers

ExchangeASX

FIGIBBG00CZTG7W3

ISINAU0000160921

CountryAustralia

Sub-IndustryLaboratory Diagnostic & Testing Substances

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

GH Guardant Health Inc -1.46% BIM.PA Biomerieux SA +0.14% TXG 10X Genomics Inc -3.54% LNTH Lantheus Holdings Inc +0.01% CAI Caris Life Sciences Inc -1.71%

Company Profile

BCAL Diagnostics Limited is an Australia-based biotechnology company. The Company develops early, non-invasive blood test-based diagnostic technologies designed to complement mammograms and improve breast cancer screening outcomes. Its commercial laboratory, equipped with Liquid Chromatography Mass Spectrometry (LCMS) technology, is focused on scientific innovation and clinical service delivery, supporting both ongoing research and the commercial rollout of our diagnostic test. The Company develops a blood test for breast cancer screening and diagnosis. The assay measures a panel of lipids in blood plasma using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Its lipid measurements are converted to a test score using a proprietary diagnostic algorithm. It offers BREASTEST plus, which is a blood test designed to be used alongside a mammogram in breast cancer screening. It provides information for women with dense breasts to help rule out the presence of breast cancer.